Page 11 Volume 19 - N2 - 2011

Dor (2011) 19
de valorização da sua sintomatologia, independen- 9. Allen RP, Connor JR, Hyland K, Earley CJ. Abnormally increased
temente da doença de base. No caso descrito, CSF-3-ortho-methyldopa (3-OMD) in untreated restless legs syn-
drome (RLS) patients indicates more severe disease and possibly
um transtorno do sono até então não diagnosti- abnormally increased dopamine synthesis. Sleep Med. 2009;
cado, num doente com múltiplas comorbilida- 10(1):123-8.
des, perturbou o normal desenrolar do progra- 10. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate
system play a role in the restless legs syndrome: a pilot post-mortem
ma de reabilitação, tendo sido premente a sua study. J Neurol Sci. 2009;279(1-2):62-5.
correcção, de forma a permitir a evolução fun- 11. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: © Permanyer Portugal 2011
diagnostic criteria, special consideration and epidemiology. A re-
cional esperada. port from the restless legs syndrome diagnosis and epidemiology
workshop at the National Institute of Health. Sleep Med. 2003;4(2):
101-19.
Bibliografia 12. Lee SJ, Kim JS, Song IU, An JY, Kim YI, Lee KS. Poststroke restless
1. National Heart, Lung, and Blood Institute Working Group on Restless legs syndrome and lesion location: anatomical considerations. Mov
Legs Syndrome. Restless legs syndrome – Detection and manage- disord. 2009;24(1):77-84.
ment in primary care. Am Fam Phys. 2000;62(1):108-14. 13. Ondo W, Jankovic J. Restless legs syndrome clinicoethiologic cor-
2. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini- relates. Neurology. 1996;47(6):1435-41.
Strambi L. The REST (RLS epidemiology, symptoms and treatment) 14. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey
primary care study. Sleep Med. 2004;5(3):237-46. B. Exercise and restless legs syndrome: a randomized controlled
3. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemi- trial. J Am Board Fam Med. 2006;19(5):487-93.
ology of restless legs symptoms in adults. Arch Intern Med. 2000;160 15. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemi-
(14):2137-41. ology of restless legs symptoms in adults. Arch Intern Med.
4. Bayard M, Avonda T, Wadzinski J. Restless legs syndrome. Am Fam 2000;160(14):2137-41.
Physician. 2008;78(2):235-40. 16. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International
5. Ondo W. Restless legs syndrome. Neurol Clin. 2009;27(3):779-99, vii. Restless Legs Syndrome Study Group rating scale for restless legs
6. Winkelman JW. Considering the causes of RLS. Eur J Neurol. syndrome. Sleep Med. 2003;4(2):121-32.
2006;13 Suppl 3:8-14. 17. Masuko AH, Carvalho LB, Machado MA, Morais JF, Prado LB,
7. Winkelman J, Muller-Myhsok B, Wittchen HU, et al. Complex segre- Prado GF. Translation and validation into the Brazilian Portuguese
gation analysis of restless legs syndrome provides evidence for an of the restless legs syndrome rating scale of the International Rest-
autossomal dominant mode of inheritance in early age at onset less Legs Syndrome Study Group. Arq Neuropsiquiatr. 2008;66(4):
families. Ann Neurol. 2002;52(3):297-302. 832-6.
8. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examina- 18. Stiasny K, Wetter TC, Winkelmann J, et al. Long-term effects of
tion suggests impaired brain iron acquisition in restless legs syn- pergolide in the treatment of restless legs syndrome. Neurology.
drome. Neurology. 2003;61(3):304-9. 2001;56(10):1339-402. Sem o consentimento prévio por escrito do editor, não se pode reproduzir nem fotocopiar nenhuma parte desta publicação

DOR

10